SANDOZ ABIRATERONE
SANDOZ ABIRATERONE
Approved
DIN Number
02521644
Drug Class
Human
Market Date
Mar 28, 2022
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02521644
AIG Number0152948002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BX03 ABIRATERONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ABIRATERONE ACETATEActive
Strength: 500 MG
Monograph: ABIRATERONE ACETATE